Anthropic Passes OpenAI in Revenue, Cerebras Files IPO, Sora Shuts Down
In this episode, we explore the unexpected growth of app launches due to AI advancements, contrary to the narrative of AI undermining traditional apps. We also discuss OpenAI's significant changes, An...
20 Apr 14min
Codex Upgrades: What You Need to Know
In this episode, we provide a comprehensive look at the recent upgrades to OpenAI's Codex. Discover key takeaways for developers and tech enthusiasts. See Privacy Policy at https://art19.com/privacy ...
17 Apr 14min
Anthropic's Opus 4.7 and the $2 Billion Impact
In this episode, we discuss the influence of Anthropic's Opus 4.7 alongside its impressive $2 billion funding acquisition. We also evaluate how their partnership with Google AI may affect their trajec...
16 Apr 14min
Anthropic's IPO Play, Novo Nordisk x OpenAI, and the First Brain Sensor Goes Human
Anthropic adds the Novartis CEO to its board as it gears up for an IPO — and on the same day, Novo Nordisk partners with OpenAI to supercharge drug development. We break down what this healthcare AI l...
15 Apr 15min
Altman Gets Molotov Cocktail, Zuckerberg Creates AI Clone
In this episode, we explore groundbreaking developments in the tech world, including Mark Zuckerberg's creation of an AI version of himself and Apple's revolutionary smart glasses. We also discuss the...
13 Apr 15min
Insights on Meta’s Gemini 4 Model
In this episode, we provide insights into the newly launched Gemini 4 by Meta. We also take a look at OpenAI's proposed AI policy and its implications. See Privacy Policy at https://art19.com/privacy...
9 Apr 15min
Anthropic's Mythos Found Millions of Security Vulnerabilities
In this episode, we explore Anthropic's ambitious Project Glasswing, aimed at securing critical software vulnerabilities with the powerful Claude Mythos Preview model. With a $100 million pledge to ma...
7 Apr 11min
Q1 2026 Venture Funding Hits $300B Record
In this episode, we examine the astonishing $300 billion venture funding in Q1 2026, with 80% allocated to AI startups. We also discuss the implications of new AI regulations, healthcare breakthroughs...
6 Apr 16min
